HEMAB THERAPEUTICS HOLDINGS (COAG) Institutional Ownership Changes & 13F Activity

HEMAB THERAPEUTICS HOLDINGS (COAG). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ra Capital Management, L.P., Novo Holdings A/S, Deep Track Capital, Lp, Avoro Capital Advisors Llc, and Bain Capital Life Sciences Investors, Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Manufacturers Life Insurance Company, TheBuy+18,72018,720$687.59KQ2 2026Sep 09, 2026
Citadel Advisors LlcBuy+523,450523,450$19.23MQ2 2026Sep 02, 2026
Ra Capital Management, L.P.Buy+7,808,6277,808,627$286.81MQ2 2026Aug 14, 2026
Novo Holdings A/SBuy+4,180,5504,180,550$153.55MQ2 2026Aug 14, 2026
Deep Track Capital, LpBuy+3,602,0933,602,093$132.30MQ2 2026Aug 14, 2026
Avoro Capital Advisors LlcBuy+1,925,1501,925,150$70.71MQ2 2026Aug 14, 2026
Bain Capital Life Sciences Investors, LlcBuy+1,650,0001,650,000$60.60MQ2 2026Aug 14, 2026
Price T Rowe Associates IncBuy+746,040746,040$27.40MQ2 2026Aug 14, 2026
Driehaus Capital Management LlcBuy+715,791715,791$26.29MQ2 2026Aug 14, 2026
Rock Springs Capital Management LpBuy+575,432575,432$21.14MQ2 2026Aug 14, 2026
Bellevue Group AgBuy+550,000550,000$20.20MQ2 2026Aug 14, 2026
Deerfield Management Company, L.P.Buy+275,000275,000$10.10MQ2 2026Aug 14, 2026
Exoduspoint Capital Management, LpBuy+218,287218,287$8.02MQ2 2026Aug 14, 2026
Braidwell LpBuy+160,000160,000$5.88MQ2 2026Aug 14, 2026
Woodline Partners LpBuy+150,040150,040$5.51MQ2 2026Aug 14, 2026
Ensign Peak Advisors, IncBuy+115,394115,394$4.24MQ2 2026Aug 14, 2026
Charles Schwab Investment Management IncBuy+108,236108,236$3.98MQ2 2026Aug 14, 2026
Ameriprise Financial IncBuy+81,92881,928$3.01MQ2 2026Aug 14, 2026
Burkehill Global Management, LpBuy+75,00075,000$2.75MQ2 2026Aug 14, 2026
Opaleye Management Inc.Buy+47,65247,652$1.75MQ2 2026Aug 14, 2026
Parkman Healthcare Partners LlcBuy+45,00045,000$1.65MQ2 2026Aug 14, 2026
Ghisallo Capital Management LlcBuy+40,00040,000$1.47MQ2 2026Aug 14, 2026
Seven Grand Managers, LlcBuy+30,00030,000$1.10MQ2 2026Aug 14, 2026
Soros Fund Management LlcBuy+25,00025,000$918.25KQ2 2026Aug 14, 2026
Xtx Topco LtdBuy+17,38917,389$638.70KQ2 2026Aug 14, 2026
Hudson Bay Capital Management LpBuy+12,20212,202$448.18KQ2 2026Aug 14, 2026
Schonfeld Strategic Advisors LlcBuy+10,81310,813$397.16KQ2 2026Aug 14, 2026
Weiss Asset Management LpBuy+10,00010,000$367.30KQ2 2026Aug 14, 2026
Squarepoint Ops LlcBuy+6,2526,252$229.64KQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+5,6805,680$208.63KQ2 2026Aug 14, 2026
Showing 30 of 55

Frequently asked questions about COAG activity

  • Which institutional owners are buying COAG?

    Institutional owners buying COAG include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in COAG activity?

    "Buy" means an investor increased their reported position in COAG compared to the prior reporting period. This reflects growing exposure to HEMAB THERAPEUTICS HOLDINGS (COAG) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in COAG increasing?

    Institutional interest in COAG can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.